Overview
- NuScale filed to raise its authorized capital to 662 million shares from 332 million, with board approval at a Dec. 16 special meeting and a filing to Delaware authorities.
- Shares fell 8.12% on Wednesday, extending a four-day losing streak, and they are down nearly 30% since mid-November, reflecting investor concern about potential dilution.
- The company reported a third-quarter net loss of $273 million versus $17 million a year earlier, while revenue rose to $8.2 million.
- Virtu Financial disclosed a new position of 579,353 NuScale shares valued at about $20.86 million in a Nov. 14 SEC filing.
- NuScale holds an NRC-approved SMR design and cites commercial pathways through an exclusive ENTRA1 partnership, reported TVA-related opportunities, and planned projects including one in Romania.